The pharmaceutical industry's daily news monitor, with emphasis on the sales and marketing of approved drugs, label expansions, patent expirations, and post-approval market development.
Audience:   Senior business executives, brand managers, operations directors, and sales and marketing leaders at pharmaceuticals.

Key Topics: Pharma company news, generic drug companies, pharmaceutical marketing and sales, FDA regulations and warnings, Phase IV clinical trials, contract manufacturing, label expansions, patent expirations, post-approval market development

Newsletter Frequency: Daily

Email Subscribers: 85,000

Monthly page views: 287,600

Reader Demographics

Company Type
Pharmaceutical - 35%
CRO/CMO/Contract Outsourcing - 18%
Biotechnology - 16%
Healthcare/Medical - 6%
Marketing / Ad Agency - 5%
Financial/Legal - 3%
Devices/Diagnostics - 2%
IT/IS/Bioinformatics - 2%
Instruments/Materials - 2%
Government - 1%
Other - 11%

Job Function
Clinical Operations - 15%
Pharma Sales - 15%
CEO / C-Level Executive - 12%
Licensing / Biz Dev - 10%
Marketing / Brand Mgmt - 9%
R&D / Engineering - 8%
Regulatory / Compliance / Safety - 5%
Manufacturing / Packaging - 3%
Medical Affairs - 3%
Finance / Legal - 3%
QA / QC - 2%
IT / IS / Bioinformatics - 2%
Other - 13%

Region
North America - 76%
Europe - 12%
South Asia - 5%
East Asia - 2%
Australia/NZ - 2%
Other - 3%

View Rates

Enter your contact information to see current rates and packages.

Top Companies Represented

Pfizer
GSK
Merck
Amgen
J&J
Abbott
Bristol Myers Squibb
Genentech
Hoffman LaRoche
Eli Lilly
Schering-Plough
Aventis
AstraZeneca
Boehringer Ingelheim
Bayer
Sanofi
Baxter
Allergan
Novartis
MedImmune
Gilead
Takeda
Genzyme
Cephalon
Novo Nordisk
Vertex
Procter & Gamble
Elan
Covance